Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus
- 1 October 1998
- journal article
- research article
- Published by Wiley in Molecular Microbiology
- Vol. 30 (1) , 209-219
Abstract
The hyaluronic acid capsule of group A Streptococcus (GAS) is an important virulence factor, but little is known about mechanisms that regulate capsule expression. Transposon Tn916 mutagenesis of the poorly encapsulated M‐type 3 GAS strain DLS003 produced a transconjugant that exhibited a mucoid colony morphology, reflecting increased hyaluronic acid capsule production. Analysis of chromosomal DNA sequence immediately downstream of the transposon insertion identified two open reading frames, designated csrR and csrS, which exhibited sequence similarity to bacterial two‐component regulatory systems. We constructed an in‐frame deletion mutation within csrR, which encodes the putative response component. Replacement of the native csrR gene in the DLS003 chromosome with the mutant allele resulted in a sixfold increase in capsule production and a corresponding increase in transcription of the has operon, which contains the essential genes for hyaluronic acid synthesis. Increased capsule production by the csrR mutant strain was associated with enhanced resistance to complement‐mediated opsonophagocytic killing in vitro and with a 500‐fold increase in virulence in mice. These results establish CsrR as a negative regulator of hyaluronic acid capsule synthesis and suggest that it is part of a two‐component regulatory system that influences capsule expression and virulence.Keywords
This publication has 52 references indexed in Scilit:
- Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection.Journal of Clinical Investigation, 1998
- What is the size of the group A streptococcal vir regulon? The Mga regulator affects expression of secreted and surface virulence factorsMedical Microbiology and Immunology, 1996
- Invasive Group A Streptococcal Infections in Ontario, CanadaNew England Journal of Medicine, 1996
- The identification of rofA, a positive‐acting regulatory component of prtF expression: use of an mγδ‐based shuttle mutagenesis strategy in Streptococcus pyogenesMolecular Microbiology, 1994
- COMMUNICATION MODULES IN BACTERIAL SIGNALING PROTEINSAnnual Review of Genetics, 1992
- Epidemiologic Analysis of Group A Streptococcal Serotypes Associated with Severe Systemic Infections, Rheumatic Fever, or Uncomplicated PharyngitisThe Journal of Infectious Diseases, 1992
- Basic local alignment search toolJournal of Molecular Biology, 1990
- Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin ANew England Journal of Medicine, 1989
- Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectorsGene, 1985
- THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HÆMOLYTICUSJournal of Experimental Medicine, 1928